Entecavir to TAF Switch
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Gilead Sciences
Related studies linked through entity extraction aliases.
Is the Endoscopic Remission Evaluation, Using the CREDO 1 Index / Score in CD Patients in Clinical Remission at Baseline, Predictive of Sustained Clinical Remission Using a 2-year Follow up
- Status
- UNKNOWN
- Phase
- NA
Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Efficacy of GS-9131 Functional Monotherapy in Human Immunodeficiency Virus (HIV)-1-Infected Adults Failing a Nucleos(t)Ide Reverse Transcriptase Inhibitor-Containing Regimen With Nucleos(t)Ide Reverse Transcriptase Inhibitor Resistant Virus
- Status
- TERMINATED
- Phase
- PHASE2
Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)
- Status
- COMPLETED
- Phase
- PHASE4
Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
- Status
- COMPLETED
- Phase
- PHASE2
A Comparative Effectiveness Demonstration Project for Linkage and Retention in PrEP Care for Men Who Have Sex With Men
- Status
- TERMINATED
- Phase
- NA
Study to Evaluate the Safety and Antiviral Activity of Inarigivir Soproxil (Formerly: GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB)
- Status
- TERMINATED
- Phase
- PHASE2
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate Switching From an E/C/F/TAF Fixed-Dose Combination (FDC) Regimen or a TDF Containing Regimen to B/F/TAF FDC in Human Immunodeficiency Virus-1 (HIV-1) Infected Participants Aged ≥ 65 Years
- Status
- COMPLETED
- Phase
- PHASE3
Same-Day Treatment With Genvoya vs. EFV/TDF/3TC
- Status
- WITHDRAWN
- Phase
- NA
NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)
- Status
- TERMINATED
- Phase
- PHASE1
Assessing Differential Adherence to Medications and Quality of Life Among People Living With HIV and Comorbidities
- Status
- COMPLETED
- Phase
- N/A
Evaluating the Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for HIV Prevention During Pregnancy and Postpartum
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Seladelpar in Subjects With Hepatic Impairment and Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Validation of a Urine Assay to Measure Tenofovir Levels in Patients Taking Tenofovir Alafenamide
- Status
- COMPLETED
- Phase
- PHASE4
Idelalisib With Rituximab, Ifosfamide, Carboplatin, Etoposide (RICE) in Children and Adolescents
- Status
- WITHDRAWN
- Phase
- PHASE1
(mo)BETTA Trial in Transwomen for Optimization of ART
- Status
- TERMINATED
- Phase
- PHASE4
Rural PrEP Delivery
- Status
- COMPLETED
- Phase
- NA